PharmaCann International
Grow Group UK
About Jealousy
JELHybridTogether, Gelato #41 and Sherbert Bx1 created a wonderfully sweet and potent strain.
Bred by 
Seed Junky™ Genetics
Get green with Jealousy in the best way possible. Jealousy is an extremely strong indica-dominant strain that is a cross between Gelato #41 and Sherbert Bx1. Gelato #41’s parents are Sunset Sherbert and Thin Mint Cookies and originates from California. Sherbert Bx1 was created by backcrossing Sunset Sherbert to the original plant.
Jealousy has dense, dark green, popcorn-shaped buds with vibrant purple hues. It is filled with copious amounts of orange hairs and a layer of crystal trichomes, giving this bud a colourful and icy appearance.
The aroma is deliciously sweet, with the dominant smell of fruity citrus and vanilla and earthy undertones. The flavour is also sweet and citrusy, and has a sour and spicy aftertaste. This mouthwatering aroma and flavour is absolutely phenomenal, and its effects will make anyone envious of the high it provides.
Description provided by Wikileaf.
Information provided could come from a third-party source, and may not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
About PhCann International B.V.
PharmaCann International is a leading company in the field of pharmaceutical cannabis, operating in accordance with EU GMP standards, with vertically integrated operations including, cloning, cultivating, cannabinoid API extraction, and pharmaceutical production and packaging.
Since inception, PharmaCann International has strive in its corporate social responsibility strategy to provide patients in need of products containing high-quality cannabinoids of natural origin and to disseminate knowledge about the therapeutic use of cannabinoids.
PharmaCann’s mission is make available a wide range of medical cannabis preparations for patients, who can benefit clinically, at the right time, at the right cost and for the right indication. Quality Control
PharmaCann operates in accordance with the highest standards, including GACP, GLP, GDP and ISO 9001, ISO 14001, ISO 27001 ISO 17025. and has a world-class laboratory for testing cannabinoids and research and development.
The Company’s European pharmaceutical cannabis facility has incorporated the latest growing, extraction and packaging technology as well established scientific methodologies to develop targeted medical cannabis products.
nyskholdings.com
Further National Health-Service Information on